{ }
001122334455554433221100
001122334455554433221100

bnp paribas exane lowers procter and gamble price target to 180 dollars

BNP Paribas Exane has revised its price target for Procter & Gamble to $180 from $190 while maintaining an outperform rating. The company is a global leader in consumer products, with net sales categorized into care and hygiene (38.1%), home care and laundry (35.1%), beauty (18.1%), shaving (7.9%), and other products (0.7%).

deutsche bank lowers procter and gamble price target but maintains buy rating

Deutsche Bank has revised its price target for Procter & Gamble to $179 from $185 while maintaining a Buy rating. Procter & Gamble is a leading consumer products company, with net sales categorized into care and hygiene products (38.1%), home care and laundry products (35.1%), beauty products (18.1%), shaving products (7.9%), and other items (0.7%).

goldman sachs lowers procter and gamble price target to 161 dollars

Goldman Sachs has adjusted its price target for Procter & Gamble to $161 from $163 while maintaining a neutral rating. The company is a global leader in consumer products, with net sales categorized into care and hygiene (38.1%), home care and laundry (35.1%), beauty (18.1%), shaving (7.9%), and other products (0.7%).

wells fargo lowers procter and gamble price target while maintaining overweight rating

Wells Fargo has adjusted its price target for Procter & Gamble to $175 from $185 while maintaining an overweight rating. The company is a global leader in consumer products, with net sales categorized into care and hygiene (38.1%), home care and laundry (35.1%), beauty (18.1%), shaving (7.9%), and other products (0.7%).

bnp paribas exane lowers procter and gamble price target to 190 dollars

BNP Paribas Exane has adjusted its price target on Procter & Gamble to $190 from $191 while maintaining an outperform rating. Procter & Gamble is a leading global producer of consumer products, with net sales categorized into care and hygiene (38.1%), home care and laundry (35.1%), beauty (18.1%), shaving (7.9%), and other products (0.7%).

procter and gamble faces outlook downgrade due to weak demand trends

Procter & Gamble, a leading consumer products company, is expected to downgrade its outlook due to weak demand trends. The company's net sales are categorized into care and hygiene products (38.1%), home care and laundry products (35.1%), beauty products (18.1%), shaving products (7.9%), and other items (0.7%).

deutsche bank lowers price target on procter and gamble maintains buy rating

Deutsche Bank has adjusted its price target on Procter & Gamble to $185 from $188 while maintaining a Buy rating. Procter & Gamble is a leading consumer products company, with net sales categorized into care and hygiene products (38.1%), home care and laundry products (35.1%), beauty products (18.1%), shaving products (7.9%), and other items (0.7%).

barclays raises price target for procter and gamble to 165 dollars

Barclays has raised its price target for Procter & Gamble to $165 from $159. The company is a global leader in consumer products, with net sales categorized into care and hygiene (38.1%), home care and laundry (35.1%), beauty (18.1%), shaving (7.9%), and other products (0.7%).

procter and gamble receives buy rating from ubS analyst

Procter & Gamble Company, a leading consumer goods manufacturer, has received a Buy rating from UBS. Its net sales are categorized into care and hygiene products (38.1%), household and laundry detergents (35.1%), beauty products (18.1%), shaving products (7.9%), and other items (0.7%).

mastercard procter and gamble novartis face challenges and opportunities in market

Zacks Equity Research highlights recent performance and outlooks for major stocks, including Mastercard, Procter & Gamble, and Novartis. Mastercard has seen a 25.6% increase in shares, driven by acquisitions and digital solutions, though high operating expenses pose risks. Procter & Gamble outperformed its industry with a focus on sustainability, despite challenges in Greater China and currency volatility. Novartis faces concerns over patent losses and increased generic competition, impacting its stock performance.
Trending
Subcategory
Countries:
Companies:
Currencies:
People:

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.